NCT01526083View on ClinicalTrials.gov

Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy Volunteers
Interventions
OTHER

Lacosamide

Strength: 200 mg, Form: Tablet, Frequency: Twice daily, Duration: 9 days

OTHER

Warfarin

"Strength: 5 mg, Form: Tablet, Frequency: 1 single dose in each period~In total, during the two periods, each healthy volunteer will receive 2 single doses 3 weeks apart.~Duration: single dose"

Trial Locations (1)

Unknown

001, Zuidlaren

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY